| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/11/2009 | CN101365715A Matrix metalloproteinase 11 vaccine |
| 02/11/2009 | CN101362803A Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/11/2009 | CN101362796A B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 02/11/2009 | CN101362795A B cell epitope of epididymal protease inhibitor and antigen peptides containing thereof |
| 02/11/2009 | CN101362794A B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 02/11/2009 | CN100460510C Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/10/2009 | US7488809 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | US7488583 Fragment complementation assays for G-protein-coupled receptors and their signaling pathways |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/05/2009 | WO2009016839A1 Method for measurement of concentration of antigen |
| 02/05/2009 | WO2009015505A1 Interactions between plant species separated by species barriers and uses thereof |
| 02/05/2009 | US20090035814 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2695169A1 Compositions comprising pneumococcal antigens |
| 02/05/2009 | CA2694139A1 New compositions, methods and uses |
| 02/04/2009 | EP1299529B1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 02/04/2009 | CN101360758A Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/04/2009 | CN101357947A Preparation and application of tumour vascular targeting agent VEGF*/RIP30fusion toxin |
| 02/04/2009 | CN101357946A Cholesterol metabolic regulation protein and use thereof |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485441 Chimeric DNA-binding proteins |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | CA2423916C Compounds with a branched linker |
| 01/29/2009 | WO2009014404A2 Multifunctional protein simultaneously delivering antibodies and nanoparticles |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030182 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090029455 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | CA2720628A1 Fusion proteins |
| 01/28/2009 | EP1446426B1 Peptide purification by means of metal ion affinity chromatography |
| 01/28/2009 | CN101356271A Identification and discrimination of function interdiction anti-ED-B-fibronectin antibody |
| 01/28/2009 | CN101353663A Anti-I type diabetes fuse protein and preparation thereof |
| 01/28/2009 | CN101353375A Method for producing influenza hemagglutinin multivalent vaccine |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009010474A1 Antibody or fragment thereof recognizing avitagtm and uses thereof |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009839A1 Controlled polymerisation process |
| 01/22/2009 | WO2001092300A9 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2016102A2 Chimeric t cell receptors and related materials and methods of use |
| 01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | CN101351550A Chimaeric fusion protein with superior chaperone and folding activities |
| 01/21/2009 | CN100453648C The pET15b-PEP-1-Cat plasmid and its construction and PEP-1-CAT fusion protein and its expression |
| 01/20/2009 | US7479552 Type-1 ribosome-inactivating protein |
| 01/20/2009 | US7479543 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479539 Hedgehog fusion proteins |
| 01/20/2009 | US7479482 For treatment of neurodegenerative disorders |
| 01/20/2009 | US7479377 Genetic construct intracellular monitoring system |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/15/2009 | WO2009006732A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017056 Skin immunization using lt-sta fusion proteins |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | CA2691898A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | CA2690317A1 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/14/2009 | EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2 |
| 01/14/2009 | EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP1390389B1 Cripto blocking antibodies and uses thereof |
| 01/14/2009 | EP1360314B1 Chemically defined medium for cultured mammalian cells |